Status
ACTIVE
Global HQ
Boston, United States
Countries of investment
- United States
- United Kingdom
- Germany
- Switzerland
- Netherlands
- Israel
Investment stages
- Pre-Seed
- Seed
- Series A
- Series B
- Series C
- Growth
Industries
- Biotech
- Healthcare
About
Omega Funds is a leading international investment firm that creates and invests in life sciences companies targeting the world's most urgent medical needs. They position themselves as hands-on, science-driven partners to entrepreneurs and scientists, supporting companies from inception through to public markets.
Omega Funds is a leading international investment firm that creates and invests in life sciences companies targeting the world's most urgent medical needs. They position themselves as hands-on, science-driven partners to entrepreneurs and scientists, supporting companies from inception through to public markets.
Investment Thesis
Omega Funds is a specialized life sciences investment firm focusing on companies addressing urgent medical needs. They invest across all stages, from company creation and early-stage ventures to late-stage and public companies, primarily in North America and Europe. Their unique approach combines deep scientific expertise with a hands-on, collaborative model to build and support transformative healthcare companies from inception to exit.
Manager's Experience
The management team comprises seasoned professionals with extensive backgrounds in both life sciences investment and corporate operations. Key partners have held senior leadership roles at major pharmaceutical companies like GSK, Sanofi, and Vertex, as well as other prominent venture firms including Index Ventures and Abingworth. This unique combination of scientific, R&D, corporate development, and venture capital expertise underpins their strategy of building and investing in innovative biotech companies.
Team
Otello Stampacchia - Founder and Managing Director
Michelle Doig - Managing Director
Bernard Davitian - Partner
Paul-Peter Tak - Partner
Francesco Draetta - Partner
Dina Ciarimboli - Partner & General Counsel
Vincent Ossipow - Partner
Portfolio
Adagio Therapeutics
Arcutis Biotherapeutics
Corvus Pharmaceuticals
Editas Medicine
Gossamer Bio
Ikena Oncology
Nuvation Bio
Prevail Therapeutics
Replimune
Theseus Pharmaceuticals